Cargando…

ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia

SARS-CoV-2 infection causing the COVID-19 pandemic calls for immediate interventions to avoid viral transmission, disease progression, and subsequent excessive inflammation and tissue destruction. Primary normal human bronchial epithelial cells are among the first targets of SARS-CoV-2 infection. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Posch, W., Vosper, J., Zaderer, V., Noureen, A., Constant, S., Bellmann-Weiler, R., Lass-Flörl, C., Wilflingseder, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092264/ https://www.ncbi.nlm.nih.gov/pubmed/33906927 http://dx.doi.org/10.1128/mBio.00904-21

Ejemplares similares

ColdZyme® protects airway epithelia from infection with BA.4/5
por: Viktoria, Zaderer, et al.
Publicado: (2022)

Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
por: Zaderer, Viktoria, et al.
Publicado: (2023)

C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia
por: Posch, Wilfried, et al.
Publicado: (2021)

SARS-CoV-2–infected primary human airway epithelia illustrate mucus hypersecretion
por: Posch, Wilfried, et al.
Publicado: (2021)

Dexamethasone Promotes Aspergillus fumigatus Growth in Macrophages by Triggering M2 Repolarization via Targeting PKM2
por: Luvanda, Maureen K., et al.
Publicado: (2021)

Inactivation of SARS‐CoV‐2 and HCoV‐229E in vitro by ColdZyme® a medical device mouth spray against the common cold
por: Gudmundsdottir, Ágústa, et al.
Publicado: (2020)

Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study
por: Lindberg, B. Fredrik, et al.
Publicado: (2023)

Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model
por: Luvanda, Maureen K., et al.
Publicado: (2021)

Evaluation of ColdZyme® Mouth Spray on prevention of upper respiratory tract infections in a boy with primary immunodeficiency: a case report
por: Clarsund, Mats, et al.
Publicado: (2016)

Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epithelia
por: Zaderer, Viktoria, et al.
Publicado: (2023)

Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen
por: Jäger, Michael, et al.
Publicado: (2022)

GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events
por: Zaderer, Viktoria, et al.
Publicado: (2023)

Turning the World Upside-Down in Cellulose for Improved Culturing and Imaging of Respiratory Challenges within a Human 3D Model
por: Zaderer, Viktoria, et al.
Publicado: (2019)

Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union
por: Huijghebaert, Suzy, et al.
Publicado: (2021)

Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
por: Lafon, Eliott, et al.
Publicado: (2021)

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022)

Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
por: Diem, Gabriel, et al.
Publicado: (2023)

Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
por: Diem, Gabriel, et al.
Publicado: (2022)

Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity
por: Schönfeld, Manuela, et al.
Publicado: (2019)

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections
por: Dichtl, Stefanie, et al.
Publicado: (2022)

Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity
por: Posch, Wilfried, et al.
Publicado: (2020)

Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
por: Davison, Glen
Publicado: (2022)

Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections
por: Chandorkar, P., et al.
Publicado: (2017)

Reply to Davison, G. Comment on “Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066”
por: Huijghebaert, Suzy, et al.
Publicado: (2022)

Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees
por: Jäger, Michael, et al.
Publicado: (2022)

Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation
por: Dichtl, Stefanie, et al.
Publicado: (2023)

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Airway Epithelia
por: Johnson, Larry G., et al.
Publicado: (2003)

Caminos vecinales con técnica perma-zyme
por: Hernández Gil, José Angel
Publicado: (1992)

Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
por: Diem, Gabriel, et al.
Publicado: (2023)

The use of in vitro human airway epithelia for the development of novel antivirals
por: Huang, S., et al.
Publicado: (2016)

A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data
por: Lass-Flörl, Cornelia, et al.
Publicado: (2022)

Design and Characterization of In-One Protease-Esterase PluriZyme
por: Fernandez-Lopez, Laura, et al.
Publicado: (2022)

Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technology
por: Schöbel, H., et al.
Publicado: (2023)

Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants
por: Jäger, Michael, et al.
Publicado: (2023)

Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia
por: Essaidi-Laziosi, Manel, et al.
Publicado: (2020)

Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in reconstituted human airway epithelia
por: Bovard, David, et al.
Publicado: (2021)

Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients
por: Fuchs, Stefan, et al.
Publicado: (2019)

Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New
por: Lackner, Nina, et al.
Publicado: (2021)

Author Correction: Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia
por: Essaidi-Laziosi, Manel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fea4r2aiqi95e01rfirqs0f2ie